Insider Buying and Selling - NUVL

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
12/08/2025 10b5-1	12/10/2025	Balcom Alexandra Chief Financial Officer CFO	Sell	-7,084 @ $110.32	($781,537.04)	54,650	(-11.48%)	Direct
11/24/2025 10b5-1	11/26/2025	Shair Matthew Director	Sell	-5,850 @ $109.37	($639,813.64)	1,377,194	(-0.42%)	Direct
10/28/2025 10b5-1	10/29/2025	Shair Matthew Director	Sell	-32,455 @ $100.27	($3,254,262.85)	1,383,044	(-2.29%)	Direct
10/27/2025 10b5-1	10/29/2025	Shair Matthew Director	Sell	-14,345 @ $100.23	($1,437,799.35)	1,415,499	(-1.00%)	Direct
01/06/2025 10b5-1	01/08/2025	Balcom Alexandra Chief Financial Officer CFO	Sell	-4,016 @ $79.68	($320,009.01)	61,734	(-6.11%)	Direct
01/06/2025 10b5-1	01/08/2025	Miller Deborah Ann Chief Legal Officer Officer	Sell	-2,964 @ $79.68	($236,182.46)	49,086	(-5.69%)	Direct
01/06/2025 10b5-1	01/08/2025	Noci Darlene Chief Development Officer Officer	Sell	-4,016 @ $79.68	($320,009.01)	48,034	(-7.72%)	Direct
01/06/2025 10b5-1	01/08/2025	Pelish Henry E. Chief Scientific Officer Officer	Sell	-2,483 @ $79.68	($197,853.82)	59,981	(-3.98%)	Direct
01/06/2025 10b5-1	01/08/2025	Porter James Richard President and CEO CEO Director	Sell	-17,301 @ $79.68	($1,378,603.83)	249,062	(-6.50%)	Direct
01/06/2025 10b5-1	01/08/2025	Turner Christopher Durant Chief Medical Officer Officer	Sell	-4,016 @ $79.68	($320,009.01)	62,547	(-6.03%)	Direct

Nuvalent, Inc. - NUVL